382 related articles for article (PubMed ID: 24892622)
21. Cationic lipid polymerization as a novel approach for constructing new DNA delivery agents.
Wu J; Lizarzaburu ME; Kurth MJ; Liu L; Wege H; Zern MA; Nantz MH
Bioconjug Chem; 2001; 12(2):251-7. PubMed ID: 11312686
[TBL] [Abstract][Full Text] [Related]
22. Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA.
Jensen DK; Jensen LB; Koocheki S; Bengtson L; Cun D; Nielsen HM; Foged C
J Control Release; 2012 Jan; 157(1):141-8. PubMed ID: 21864597
[TBL] [Abstract][Full Text] [Related]
23. Characterization of cationic lipid DNA transfection complexes differing in susceptability to serum inhibition.
Nchinda G; Uberla K; Zschörnig O
BMC Biotechnol; 2002 Jul; 2():12. PubMed ID: 12113654
[TBL] [Abstract][Full Text] [Related]
24. Lipoplexes versus nanoparticles: pDNA/siRNA delivery.
Khurana B; Goyal AK; Budhiraja A; Aora D; Vyas SP
Drug Deliv; 2013 Feb; 20(2):57-64. PubMed ID: 23537464
[TBL] [Abstract][Full Text] [Related]
25. Multifunctional nanocarrier based on clay nanotubes for efficient intracellular siRNA delivery and gene silencing.
Wu H; Shi Y; Huang C; Zhang Y; Wu J; Shen H; Jia N
J Biomater Appl; 2014 Apr; 28(8):1180-9. PubMed ID: 23985535
[TBL] [Abstract][Full Text] [Related]
26. Lipoplexes from Non-viral Cationic Vectors: DOTAP-DOPE Liposomes and Gemini Micelles.
Falsini S; Ristori S
Methods Mol Biol; 2016; 1445():33-43. PubMed ID: 27436311
[TBL] [Abstract][Full Text] [Related]
27. Optimization and physicochemical characterization of a cationic lipid-phosphatidylcholine mixed emulsion formulated as a highly efficient vehicle that facilitates adenoviral gene transfer.
Kim SY; Lee SJ; Kim JK; Choi HG; Lim SJ
Int J Nanomedicine; 2017; 12():7323-7335. PubMed ID: 29070949
[TBL] [Abstract][Full Text] [Related]
28. Efficient short interference RNA delivery to tumor cells using a combination of octaarginine, GALA and tumor-specific, cleavable polyethylene glycol system.
Sakurai Y; Hatakeyama H; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
Biol Pharm Bull; 2009 May; 32(5):928-32. PubMed ID: 19420766
[TBL] [Abstract][Full Text] [Related]
29. Development and characterization of a novel cationic PEGylated niosome-encapsulated forms of doxorubicin, quercetin and siRNA for the treatment of cancer by using combination therapy.
Hemati M; Haghiralsadat F; Yazdian F; Jafari F; Moradi A; Malekpour-Dehkordi Z
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1295-1311. PubMed ID: 30033768
[TBL] [Abstract][Full Text] [Related]
30. Chitosan-lipid nanoparticles (CS-LNPs): Application to siRNA delivery.
Tezgel Ö; Szarpak-Jankowska A; Arnould A; Auzély-Velty R; Texier I
J Colloid Interface Sci; 2018 Jan; 510():45-56. PubMed ID: 28934610
[TBL] [Abstract][Full Text] [Related]
31. Preparation and optimization of PIT solid lipid nanoparticles via statistical factorial design.
Carbone C; Tomasello B; Ruozi B; Renis M; Puglisi G
Eur J Med Chem; 2012 Mar; 49():110-7. PubMed ID: 22244589
[TBL] [Abstract][Full Text] [Related]
32. Tf-lipoplexes for neuronal siRNA delivery: a promising system to mediate gene silencing in the CNS.
Cardoso AL; Simões S; de Almeida LP; Plesnila N; Pedroso de Lima MC; Wagner E; Culmsee C
J Control Release; 2008 Dec; 132(2):113-23. PubMed ID: 18796321
[TBL] [Abstract][Full Text] [Related]
33. Non-Covalently Functionalized of Single-Walled Carbon Nanotubes by DSPE-PEG-PEI for SiRNA Delivery.
Siu KS; Zhang Y; Zheng X; Koropatnick J; Min WP
Methods Mol Biol; 2016; 1364():151-63. PubMed ID: 26472449
[TBL] [Abstract][Full Text] [Related]
34. Synergistic anticancer effect of RNAi and photothermal therapy mediated by functionalized single-walled carbon nanotubes.
Wang L; Shi J; Zhang H; Li H; Gao Y; Wang Z; Wang H; Li L; Zhang C; Chen C; Zhang Z; Zhang Y
Biomaterials; 2013 Jan; 34(1):262-74. PubMed ID: 23046752
[TBL] [Abstract][Full Text] [Related]
35. Novel biotinylated chitosan-graft-polyethyleneimine copolymer as a targeted non-viral vector for anti-EGF receptor siRNA delivery in cancer cells.
Darvishi MH; Nomani A; Amini M; Shokrgozar MA; Dinarvand R
Int J Pharm; 2013 Nov; 456(2):408-16. PubMed ID: 24012865
[TBL] [Abstract][Full Text] [Related]
36. Nonviral vector for efficient gene transfer to human ovarian adenocarcinoma cells.
Kim CK; Haider KH; Choi SH; Choi EJ; Ahn WS; Kim YB
Gynecol Oncol; 2002 Jan; 84(1):85-93. PubMed ID: 11748982
[TBL] [Abstract][Full Text] [Related]
37. Serum-resistant lipopolyplexes for gene delivery to liver tumour cells.
García L; Buñuales M; Düzgüneş N; Tros de Ilarduya C
Eur J Pharm Biopharm; 2007 Aug; 67(1):58-66. PubMed ID: 17321729
[TBL] [Abstract][Full Text] [Related]
38. Single-walled carbon nanotubes functionalized with aptamer and piperazine-polyethylenimine derivative for targeted siRNA delivery into breast cancer cells.
Mohammadi M; Salmasi Z; Hashemi M; Mosaffa F; Abnous K; Ramezani M
Int J Pharm; 2015 May; 485(1-2):50-60. PubMed ID: 25712164
[TBL] [Abstract][Full Text] [Related]
39. Mechanistic profiling of the siRNA delivery dynamics of lipid-polymer hybrid nanoparticles.
Colombo S; Cun D; Remaut K; Bunker M; Zhang J; Martin-Bertelsen B; Yaghmur A; Braeckmans K; Nielsen HM; Foged C
J Control Release; 2015 Mar; 201():22-31. PubMed ID: 25540904
[TBL] [Abstract][Full Text] [Related]
40. Enhanced cellular uptake and gene silencing activity of siRNA using temperature-responsive polymer-modified liposome.
Wang J; Ayano E; Maitani Y; Kanazawa H
Int J Pharm; 2017 May; 523(1):217-228. PubMed ID: 28330734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
